Compliance with GDP (Good Distribution Practice) guidelines goes far beyond documenting delivery and quality processes – contracts must also be regularly reviewed and assessed for regulatory conformity. Especially in an international context with multilingual documentation, this is a demanding and time-consuming task prone to human error. Our AI solution for pharma audits supports you in reviewing contracts efficiently, reliably, and in full compliance with GDP requirements, ensuring transparency and security in a particularly sensitive area.
In the pharmaceutical sector, data is particularly sensitive. That’s why we place the utmost importance on ensuring that your information is protected at all times – from upload to processing within the system. Your data is never stored permanently and is not used for AI model training.
We adhere to the principles of OWASP (Open Worldwide Application Security Project), a globally recognized organization for software security. This means we continuously analyze major security risks, adapt our protective measures accordingly, and apply proven best practices in the development and safeguarding of our solutions.
Our systems are also protected against typical types of attacks. For example, our security mechanisms detect and block DDoS (Distributed Denial of Service) attacks at an early stage, attacks aimed at overloading systems with massive request volumes. Likewise, a strict identity and access management system reliably prevents unauthorized access to confidential data.
We ensure maximum data protection so that your documents remain secure at all times. At the same time, our systems are designed for high availability, remaining stable and reliable even under attack. Furthermore, our security configurations are regularly reviewed and optimized by experts to ensure sustainable data protection.
